A marketing blend of three separate research peptides sold in one vial. No trial has ever tested the combination — the evidence, such as it is, belongs to the individual components.
The "Glow protocol" packages BPC-157, TB-500 and GHK-Cu together and markets the combination for skin, hair and recovery. Each of those three has its own literature, and each has its own limits — mostly animal work for the first two, mostly topical and in-vitro work for the third. Combining them does not combine their evidence. Nobody has tested whether the three interact, whether they are stable together in one vial, or whether the mixture does anything the components do not.
A compounded blend, typically BPC-157 (pentadecapeptide, gastric juice-derived, angiogenic and tendon-healing signal in rodent models), TB-500 (LKKTETQ actin-binding fragment of thymosin beta-4), and GHK-Cu (copper-binding tripeptide with documented effects on collagen and matrix remodelling, largely from topical and in-vitro work). Ratios vary between suppliers. There is no published pharmacokinetic, stability or interaction data for the combination, and copper-peptide chemistry in particular raises formulation questions when mixed with other peptides in solution.
Research areas
Community-specified data
Source note: Yields 2.5mg GHK-CU / 1mg BPC / 1mg TB4
Not medical guidance. These third-party figures have not been independently verified, clinically reviewed, or endorsed by DB Peptide. They may be inaccurate or unsafe and should not replace product labelling or advice from a qualified clinician.
Every protocol below is reproduced from a published study or approved labelling, with its source named. These are records of what was studied — not recommendations, and not a suggestion that any of them is appropriate for any person.
| Protocol as reported | Source |
|---|---|
| Vendor-published blend protocols, typically a fixed daily subcutaneous dose over 4–8 weeksNot derived from any published study. Included here to describe what circulates, not to endorse it. | Supplier marketing material |
No trials of the combination in any species. Component evidence is described on the individual profiles.
There is no evidence either way, because no study has compared them. What is knowable is that a blend removes your ability to change one variable at a time, and it makes any adverse effect impossible to attribute.
Medical disclaimer
This page is for informational and research purposes only. Nothing here constitutes medical advice. The compounds discussed are research chemicals. Consult a qualified clinician before starting any protocol.
How this profile was built →